Table 1.
Study specimens | N | Percentage with this specimen type |
n positive by specimen |
% positive overall |
Percentage of all positives identified by this specimen type |
95% CI | RSV positives from any source among patients with results by that specimen type |
Sensitivity* | 95% CI |
---|---|---|---|---|---|---|---|---|---|
Overall | 1766 | 100.0% | 109 | 6.2% | N/A | N/A | 109 | N/A | N/A |
NP swab | 1766 | 100.0% | 56 | 3.2% | 51.4% | 42.0–60.8% | 109 | 51.4% | 42.0–60.8% |
Saliva** | 1740 | 98.5% | 75 | 4.3% | 68.8% | 60.1–77.5% | 107 | 70.1% | 61.4–78.8% |
Sputum | 606 | 34.3% | 41 | 6.8% | 37.6% | 28.5–46.7% | 57 | 71.9% | 60.3–83.6% |
Serology | 367 | 20.8% | 23 | 6.3% | 21.1% | 13.4%-28.8% | 29 | 79.3% | 64.6–94.1% |
*Sensitivity is limited to those with results with that specimen type, i.e., count of positives by that specimen type divided by count of all positives from any source among those with results by that specimen type
**In subjects that were unable to produce saliva, a saline mouth wash was obtained